Sign In
Buy ELEV
$0.365
+0 (+0%)
At Close: Oct 22, 2025
Elevation Oncology Reports Third Quarter 2023 Financial Results and Highlights Recent Business Achievements
07:30am, Thursday, 02'nd Nov 2023
-- Enrollment is ongoing in the Phase 1 clinical trial evaluating EO-3021 in patients with advanced solid tumors likely to express Claudin 18.2; preliminary safety and anti-tumor activity data expecte
Elevation Oncology to Present at the H.C. Wainwright 25th Annual Global Investment Conference
07:30am, Tuesday, 05'th Sep 2023
NEW YORK , Sept. 5, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patien
Elevation Oncology Announces First Patient Dosed in the Phase 1 Clinical Trial Evaluating EO-3021
07:30am, Wednesday, 16'th Aug 2023
NEW YORK, Aug. 16, 2023 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients
Why Is Elevation Oncology (ELEV) Stock Down 26% Today?
08:48am, Friday, 09'th Jun 2023
Elevation Oncology (NASDAQ: ELEV ) stock is taking a beating on Friday after the healthcare company announced a public stock offering. That public offering of ELEV stock has the company selling 17,81
Steve Cohen's Point72 Disclosed 8.7% Stake In Elevation Oncology
06:56am, Tuesday, 30'th May 2023
Elevation Oncology NASDAQ: ELEV is a biotech company that focuses on discovering and developing cancer therapies. The company aims to treat patients with various solid tumors with significant unmet me
Why Is Elevation Oncology (ELEV) Stock Up 57% Today?
10:06am, Friday, 26'th May 2023
Elevation Oncology (NASDAQ: ELEV ) stock is on the rise Friday despite a lack of news from the pharmaceutical company. There's no news that explains why shares of ELEV stock are taking off today.
5 Penny Stocks To Watch Before Next Week; Time To Buy?
06:21pm, Thursday, 25'th May 2023
If you're like many retail traders in the stock market today, penny stocks are a popular prospect. This article looks at some of the most active penny stocks today with late-breaking momentum.
Are Medical Stocks Lagging Elevation Oncology (ELEV) This Year?
11:28am, Thursday, 23'rd Mar 2023
Here is how Elevation Oncology, Inc. (ELEV) and Senesco Technologies Inc. (ELOX) have performed compared to their sector so far this year.
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
04:03am, Thursday, 26'th Jan 2023
The 2023 calendar year has already been rocky for many biotech companies. Just three weeks into the new year, layoffs are already plaguing the industry.
Positive initial data support the potential of seribantumab to induce deep and durable benefit for patients with tumors harboring NRG1 fusions Clinical activity observed includes a 33% response rate w
Best Penny Stocks to Buy as May Ends? 3 to Watch Right Now
04:51pm, Wednesday, 25'th May 2022
Check these penny stocks out for your watchlist The post Best Penny Stocks to Buy as May Ends? 3 to Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c
Why Elevation Oncology Stock Is Rising
10:22am, Wednesday, 25'th May 2022
Elevation Oncology Inc (NASDAQ: ELEV) shares are trading higher Wednesday after the company announced the U.S. Food and Drug Administration granted Fast Track designation to seribantumab for the tum
Elevation Oncology GAAP EPS of -$0.41 beats by $0.18
01:39pm, Thursday, 03'rd Mar 2022 Seeking Alpha
Elevation Oncology press release (ELEV): Q4 GAAP EPS of -$0.41 beats by $0.18.As of December 31, 2021, the Company had cash and cash equivalents totaling $146.3M
Elevation Oncology Reports Fourth Quarter and Full Year 2021 Financial Results
12:30pm, Thursday, 03'rd Mar 2022 PR Newswire
NEW YORK, March 3, 2022 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, today announced financial results for the year ended December 31,…
Elevation Oncology, Inc.s (NASDAQ:ELEV) Lock-Up Period Set To Expire on December 22nd
06:20am, Wednesday, 22'nd Dec 2021 Transcript Daily
Elevation Oncologys (NASDAQ:ELEV) lock-up period will expire on Wednesday, December 22nd. Elevation Oncology had issued 6,250,000 shares in its IPO on June 25th. The total size of the offering was $100,000,000 based on an initial share price of $16.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade []
